
electroCore Investor Relations Material
Latest events

Q1 2025
electroCore
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from electroCore Inc
Access all reports
electroCore Inc is a commercial-stage medical technology company that develops and markets non-invasive neuromodulation devices. Its primary product, a handheld device, uses electrical stimulation to target the vagus nerve for the treatment of various conditions, including migraines and cluster headaches. The company’s technology is designed to offer patients a non-drug, non-invasive alternative for pain management and neurological disorders. electroCore is also exploring the potential use of its platform in other therapeutic areas such as respiratory diseases and inflammatory conditions. The company is headquartered in Rockaway, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
ECOR
Country
🇺🇸 United States